Twirla: payments to doctors
Payments that named Twirla as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $2.1M
- Providers
- 10,606
- Transactions
- 27,087
- Average per transaction
- $78
The per-transaction average — $78 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 10,606 providers the average total is $200, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Agile Therapeutics, Inc. | $1,094,005 | 51.5% |
| Exeltis, USA Inc. | $1,030,891 | 48.5% |